Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Panakeia
AI pathology platform
Diagnostics & imaging
Cambridge AI pathology company whose software reads standard tumour tissue slides to deliver molecular cancer profiling in minutes rather than the weeks conventional genomic testing takes.
The read
Panakeia's AI reads standard haematoxylin and eosin-stained tissue slides, the routine images pathology labs already produce, to infer molecular markers such as microsatellite instability and mismatch repair status directly from the image, rather than requiring separate genomic sequencing that can take weeks to return results.
Its PANProfiler Colorectal product is UKCA marked, and a January 2026 clinical validation study led by Leeds Teaching Hospitals NHS Trust reported it could deliver rapid molecular profiling for colorectal cancer patients directly from existing pathology workflows. The company has also been selected into the MHRA's AI Airlock programme, a regulatory sandbox for higher-risk AI medical devices.
The Bridgehead view
Panakeia's pitch, turning a slide pathology labs already have into a molecular test they'd otherwise wait weeks for, is the clearest example in this cohort of AI diagnostics competing on turnaround time rather than accuracy claims alone, a more concrete story for procurement conversations than most.
FAQs
About this page
No. The MedTech Index is independent editorial coverage — we track and write up companies we judge genuinely significant in the sector, and inclusion is not for sale. Where shown, coverage of Panakeia above is drawn from public reporting, not sponsored content.
We map the sector by who is actually shaping it: funding, product reach, regulatory engagement and the coverage they earn. The MedTech Index is maintained by our editorial team and updated as the market moves, not compiled from vendor submissions.
Yes. If you represent Panakeia, or anything here looks out of date, get in touch through our contact page and we will review it.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
Others in the sector map
AI cancer pathology and genomics platform
Sonrai Analytics
Belfast-founded, Queen's University spinout building an AI platform that reads cancer biopsy slides and multi-omic data to support faster, more consistent pathology diagnosis.
ReadRare disease diagnosis AI
Mendelian
AI clinical decision support that scans GP electronic health records to flag patients who may have one of thousands of rare diseases, years earlier than standard care typically catches them.
ReadSelf-test IVD manufacturer
BioSure
Essex-based manufacturer of CE-marked self-test IVDs, best known for producing the world's first CE-marked HIV self-test, sold through UK pharmacies and the NHS.
ReadLateral-flow diagnostics manufacturer
SureScreen Diagnostics
Derby-based, family-run manufacturer of lateral-flow and rapid diagnostic test kits, an NHS supplier since 2010 that produced 20 million UK-manufactured rapid COVID-19 tests for the UK government.
ReadLung cancer diagnosis AI
Optellum
AI decision-support software that stratifies the cancer risk of lung nodules found on CT scans, the first such tool cleared by the FDA.
ReadStroke and lung imaging AI
Brainomix
Oxford University spinout building AI imaging biomarkers for stroke and lung disease, used to speed emergency treatment decisions from CT and MRI scans.
ReadThe firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
